Medication ManagementNCT06018662
An Interventional Study to Establish a Medication Management Mobile Application for Pediatric Surgery Patients
A study testing A medication management mobile application in people with Medication Management, run by Ain Shams University at 1 site in Egypt.
Trial summary
An interventional study that aims to design, establish and implement an electronic application for management of the usage of anesthetics, antimicrobials, and analgesics in a pediatric surgery department, and assess the impact of the implementation of an electronic medication management application on the… Read more about this study
- Who is it for?
- Ages 1 year to 12 years
- Conditions the study is for
- Medication Management
- What is being tested?
- A medication management mobile application
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 276 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Nov 2023to 1 Dec 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 1 year to 12 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Pediatric patients undergoing any of the following surgeries: Circumcision, Inguinal Hernia, Hypospadias, Esophageal dilatation, uncomplicated Appendectomy, and complicated Appendectomy
Who cannot join
- Cardiac patients
- Diabetic patients
- Hypertensive patients
- Immunocompromised patients
- Patients with renal and/or liver failure
Trial locations and contacts
1 site in 1 country.
Egypt1 site, 1 recruiting
- Recruiting
Ain Shams University
Cairo, Nasr City
Mai Fawaz, Master's
About this study
Official title: Establishment of an Electronic Medication Management Application in a Pediatric Surgery Department
An interventional study that aims to design, establish and implement an electronic application for management of the usage of anesthetics, antimicrobials, and analgesics in a pediatric surgery department, and assess the impact of the implementation of an electronic medication management application on the appropriateness of medication use in a pediatric surgery department
Read the detailed description
Mobile health (mHealth) refers to digital health technologies via mobile phones, tablets, and other electronic devices to enhance health outcomes. mHealth has started to have an impact on many health care and medical education aspects. With the increased number of smartphones and increasing interest in using mobile applications (apps), healthcare related mobile apps offer opportunities for advanced patient care allowing for better patient-provider communication. Within anesthesia, mobile apps were developed to play an important role; pre, intra- and postoperatively through providing patient-physician communication, reducing patient anxiety, and offering on-the-go education.
The development of medical mobile app is challenging. It incorporates producing an easy-to-use display with appropriate clinical information. Although many medication errors lead to little or no harm, some have overwhelming consequences for patients and, sometimes, for practitioners.
In pediatric patients, doses of anesthetics and other medications are calculated based on age and/or weight. Also, preparations often require further dilutions, specifically for younger patients like neonates and infants. These steps might increase risk for medication errors in pediatric anesthesia. For pediatric patients, it is important to use appropriate weight-based medication doses.
Anesthetics, Antimicrobials and Analgesics are the three drug classes that have shown the highest number of medication errors in the operating rooms of a pediatric surgery department. To provide an appropriate age and/or weight-based drug information, we will develop an electronic application to recommend the most appropriate drugs based on international guidelines and calculate doses for Anesthetics, Antimicrobials and Analgesics for pediatric patients in the operating rooms of a pediatric surgery department.
Aim of the study:
To design, establish and implement an electronic application for management of the usage of anesthetics, antimicrobials, and analgesics in a pediatric surgery department. To assess the impact of the implementation of an electronic medication management application on the appropriateness of medication use in a pediatric surgery department
Patients and methods:
Design:
Prospective, Interventional, Single-blinded, Randomized controlled study.
Setting:
The study will be conducted in the pediatric surgery department in the Children's hospital, Ain Shams University, Cairo, Egypt.
Patients:
Pediatric patients undergoing surgical operations.
Methods:
The study will be performed according to the following phases;
Phase 1: Application Design and Development
- The app will include all database required to provide appropriate medications and dosing for pediatric patients intraoperatively, postoperatively and on discharge.
- The user will need to enter the patient's age and weight, choose the type of surgery and the drug class and the app will show the appropriate medications and dosage.
- The app will present all the important information for drug administration by using; the British National Formulary for children (BNF-C) and Lexicomp online database as the dosage and administration references, and The American Health System Pharmacists (ASHP) clinical practice guidelines and UpToDate evidence-based clinical decision support resource will be used for to determine the appropriate anesthetics, antimicrobials, and analgesics for the surgeries to be included in the study.
- The researcher will ensure that the application will be displayed properly on the iPhone operating system (iOS) and Android mobile devices.
Phase 2: Simulation and Validation
- To test app validation, a simulation study will be conducted, where, data of patient's weight and age will be entered followed by selection of type of surgery and drug class.
- The app will provide the appropriate medications and dosage for each case scenario according to international treatment protocols and guidelines.
- Medications doses in each drug class will be calculated twice using the app and twice without the app, for each type of surgery.
Phase 3: Physicians' training Physicians will be trained on how to use the application for the selected types of surgeries. (List of surgeons will be accurately checked and randomly 50% of them will be allowed to enter training sessions for use of app in their practice (interventional group), while the rest 50% will not be given the training sessions in order to use the department policy (Control group).
Phase 4: Patients' recruitment and Application use in pre-, intra-, and post-operative stage Two hundred and seventy- six 276 patients will be randomly allocated to either control group or intervention group via simple randomization technique.
Control group (138 patients): The medications selection and dosage will be performed according to the department policy without using the app.
Intervention group (138 patients): The physicians use the app for appropriate medications selection and dosage calculation.
All patients will be followed up postoperatively during hospital stay. A follow-up form will be used to record all required data during hospitalization.
Cost estimation :
Estimated cost savings will be calculated based on reduction in medication errors by using the electronic app. This will include discontinuing unnecessary medications, modifications of dose or duration, no medication indication, and inappropriate medication combination.
Medication errors categories according to the National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) will be included in the cost saving analysis.
Phase 5: Usability testing An electronic form of the System Usability Scale (SUS), a widely used and validated 10-questions Likert scale, for measuring the app usability will be used to evaluate physicians' user experience of the app.
Phase 6: Follow-up All patients will be followed up for two weeks after discharge for any signs and symptoms of drug related problems or postoperative complications including pain, nausea, vomiting and surgical site infection using an electronic form or phone calls. A follow-up form will be used after discharge
- Conditions
- Medication Management
- Being tested
- A medication management mobile application
- Keywords
- Pediatric surgery, Mobile application, Medication errors
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
A medication management mobile applicationOther
A mobile application to select the most appropriate drugs for anesthetics, antimicrobials and analgesics, in addition to dose calculations
| Study group | Role | What they receive |
|---|---|---|
| Control | No intervention | Routine department therapy |
| Interventional | Experimental | Anesthetics, antimicrobials and analgesics are selected and age/weight doses are calculated using the medication management mobile application Receives: Other: A medication management mobile application |
What is being measured
The primary outcome is the main question the study is designed to answer.
Appropriateness of medications (anesthetics, antimicrobials, and analgesics) used in different types of surgeries
Determined through measuring incidence of medication errors and drug related problems
Measured: One year
Secondary outcomes (3)
Cost saving
Estimated cost savings will be calculated by calculating direct medical costs (including medication costs (multiplied by duration in days) of the intervened medications if the interventions belong to any of the mentioned types, laboratory tests, investigations and hospital care).
Estimated cost avoidance will be calculated based on the probability score (probability of an adverse drug event in the absence of the intervention).
Measured: One year
Cost avoidance
Estimated cost avoidance will calculated based on the probability of an adverse drug event in the absence of the mobile application
Measured: one year
Time saving
Time saving resulting from using the application will be calculated in seconds
Measured: one year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Aug 2023
- Study start1 Nov 2023
- Primary completion1 Oct 2024 (estimated)
- Study completion1 Dec 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Medication ManagementStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Control group (138 patients): The medications selection and dosage will be performed according to the department policy without using the application. Intervention group (138 patients): The physicians use the application for appropriate medications selection and dosage calculation.
- Masking
- Double blind
- Who is masked
- Participant, Care provider
- Enrolment
- 276 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Ain Shams University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mai Fawaz, Ain Shams University
- Investigators
- Mai Fawaz, Master's degree, Principal investigator, Ain Shams University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06018662
- Sponsor's protocol ID
- A medication mobile app
- Status last verified
- Jan 2024
- First submitted
- 3 Aug 2023
- Last updated
- 31 Jan 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 31 Jan 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Establishment of an Electronic Medication Management Application in a Pediatric Surgery Department
- ClinicalTrials.gov ID
- NCT06018662
- Acronym / sponsor ID
- A medication mobile app
- Conditions
- Medication Management
- Keywords
- Pediatric surgery, Mobile application, Medication errors
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 276 participants (estimated)
- Lead sponsor
- Ain Shams UniversityUniversity, hospital or other
- Study start
- 1 Nov 2023 (actual)
- Primary completion
- 1 Oct 2024 (estimated)
- Study completion
- 1 Dec 2024 (estimated)
- First posted
- 30 Aug 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
An interventional study that aims to design, establish and implement an electronic application for management of the usage of anesthetics, antimicrobials, and analgesics in a pediatric surgery department, and assess the impact of the implementation of an electronic medication management application on the appropriateness of medication use in a pediatric surgery department
Detailed description
Mobile health (mHealth) refers to digital health technologies via mobile phones, tablets, and other electronic devices to enhance health outcomes. mHealth has started to have an impact on many health care and medical education aspects. With the increased number of smartphones and increasing interest in using mobile applications (apps), healthcare related mobile apps offer opportunities for advanced patient care allowing for better patient-provider communication. Within anesthesia, mobile apps were developed to play an important role; pre, intra- and postoperatively through providing patient-physician communication, reducing patient anxiety, and offering on-the-go education.
The development of medical mobile app is challenging. It incorporates producing an easy-to-use display with appropriate clinical information. Although many medication errors lead to little or no harm, some have overwhelming consequences for patients and, sometimes, for practitioners.
In pediatric patients, doses of anesthetics and other medications are calculated based on age and/or weight. Also, preparations often require further dilutions, specifically for younger patients like neonates and infants. These steps might increase risk for medication errors in pediatric anesthesia. For pediatric patients, it is important to use appropriate weight-based medication doses.
Anesthetics, Antimicrobials and Analgesics are the three drug classes that have shown the highest number of medication errors in the operating rooms of a pediatric surgery department. To provide an appropriate age and/or weight-based drug information, we will develop an electronic application to recommend the most appropriate drugs based on international guidelines and calculate doses for Anesthetics, Antimicrobials and Analgesics for pediatric patients in the operating rooms of a pediatric surgery department.
Aim of the study:
To design, establish and implement an electronic application for management of the usage of anesthetics, antimicrobials, and analgesics in a pediatric surgery department. To assess the impact of the implementation of an electronic medication management application on the appropriateness of medication use in a pediatric surgery department
Patients and methods:
Design:
Prospective, Interventional, Single-blinded, Randomized controlled study.
Setting:
The study will be conducted in the pediatric surgery department in the Children's hospital, Ain Shams University, Cairo, Egypt.
Patients:
Pediatric patients undergoing surgical operations.
Methods:
The study will be performed according to the following phases;
Phase 1: Application Design and Development
- The app will include all database required to provide appropriate medications and dosing for pediatric patients intraoperatively, postoperatively and on discharge.
- The user will need to enter the patient's age and weight, choose the type of surgery and the drug class and the app will show the appropriate medications and dosage.
- The app will present all the important information for drug administration by using; the British National Formulary for children (BNF-C) and Lexicomp online database as the dosage and administration references, and The American Health System Pharmacists (ASHP) clinical practice guidelines and UpToDate evidence-based clinical decision support resource will be used for to determine the appropriate anesthetics, antimicrobials, and analgesics for the surgeries to be included in the study.
- The researcher will ensure that the application will be displayed properly on the iPhone operating system (iOS) and Android mobile devices.
Phase 2: Simulation and Validation
- To test app validation, a simulation study will be conducted, where, data of patient's weight and age will be entered followed by selection of type of surgery and drug class.
- The app will provide the appropriate medications and dosage for each case scenario according to international treatment protocols and guidelines.
- Medications doses in each drug class will be calculated twice using the app and twice without the app, for each type of surgery.
Phase 3: Physicians' training Physicians will be trained on how to use the application for the selected types of surgeries. (List of surgeons will be accurately checked and randomly 50% of them will be allowed to enter training sessions for use of app in their practice (interventional group), while the rest 50% will not be given the training sessions in order to use the department policy (Control group).
Phase 4: Patients' recruitment and Application use in pre-, intra-, and post-operative stage Two hundred and seventy- six 276 patients will be randomly allocated to either control group or intervention group via simple randomization technique.
Control group (138 patients): The medications selection and dosage will be performed according to the department policy without using the app.
Intervention group (138 patients): The physicians use the app for appropriate medications selection and dosage calculation.
All patients will be followed up postoperatively during hospital stay. A follow-up form will be used to record all required data during hospitalization.
Cost estimation :
Estimated cost savings will be calculated based on reduction in medication errors by using the electronic app. This will include discontinuing unnecessary medications, modifications of dose or duration, no medication indication, and inappropriate medication combination.
Medication errors categories according to the National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) will be included in the cost saving analysis.
Phase 5: Usability testing An electronic form of the System Usability Scale (SUS), a widely used and validated 10-questions Likert scale, for measuring the app usability will be used to evaluate physicians' user experience of the app.
Phase 6: Follow-up All patients will be followed up for two weeks after discharge for any signs and symptoms of drug related problems or postoperative complications including pain, nausea, vomiting and surgical site infection using an electronic form or phone calls. A follow-up form will be used after discharge
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, care provider)
- Number of arms
- 2
- Model description
- Control group (138 patients): The medications selection and dosage will be performed according to the department policy without using the application. Intervention group (138 patients): The physicians use the application for appropriate medications selection and dosage calculation.
| Arm | Type | Receives |
|---|---|---|
| Control | No intervention | –Routine department therapy |
| Interventional | Experimental | Other: A medication management mobile applicationAnesthetics, antimicrobials and analgesics are selected and age/weight doses are calculated using the medication management mobile application |
Who may qualify
- Ages
- 1 year to 12 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (1 listed)
- Pediatric patients undergoing any of the following surgeries: Circumcision, Inguinal Hernia, Hypospadias, Esophageal dilatation, uncomplicated Appendectomy, and complicated Appendectomy
Key exclusion criteria (5 listed)
- Cardiac patients
- Diabetic patients
- Hypertensive patients
- Immunocompromised patients
- Patients with renal and/or liver failure
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| A medication management mobile applicationA mobile application to select the most appropriate drugs for anesthetics, antimicrobials and analgesics, in addition to dose calculations | Other | Interventional |
Primary outcome
Appropriateness of medications (anesthetics, antimicrobials, and analgesics) used in different types of surgeries
Time frame: One year
Determined through measuring incidence of medication errors and drug related problems
3 secondary outcomes
Cost saving
Time frame: One year
Cost avoidance
Time frame: one year
Time saving
Time frame: one year
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Jan 2024.
- Individual participant dataSharing planned: No
Related trials for Medication Management
Not yet recruitingObservational study
Development and Prospective Validation of the AutoEIT Foundation Model for ARDS
ARDS (Acute Respiratory Distress Syndrome), Respiratory Failure
Recruiting
Effects of Cartoons & Interactive Storytelling on Fear and Comfort in 6-9 Year Olds During Nebulizer Treatment
Distraction Methods, Nursing Care
Recruiting
IMB-Guided Health Education Intervention for Medication Adherence and Blood Pressure Control in Non-adherent Hypertensive Patients
Hypertension
RecruitingObservational study
Reduction of Adverse Drug Events and Readmissions
Pharmacogenomic Testing for Medication Management
Recruiting
ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management
Obesity, Weight Control
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mai Fawaz, Master's degree principal investigator
Ain Shams University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing A medication management mobile application in people with Medication Management, run by Ain Shams University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 31 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Mai Fawaz, Master's (+20 1221190802, May.gamal21@pharma.asu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Appropriateness of medications (anesthetics, antimicrobials, and analgesics) used in different types of surgeries (time frame: One year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jan 2024.